![Brian Liu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brian Liu
Direttore/Membro del Consiglio presso
CG ONCOLOGY, INC.
Patrimonio netto: 134 M $ in data 30/06/2026
Profilo
Brian Liu is currently Managing Director at Longitude Capital Management Co LLC since 2018.
Dr. Liu is also Director at Alentis Therapeutics AG starting in 2024, Director at Helicore Biopharma, Inc. starting in 2025, Independent Director at CG Oncology, Inc. since 2022, and Director at Lassen Therapeutics LLC since 2023.
Formerly, Dr. Liu was Engagement Manager at McKinsey & Co., Inc. from 2016 to 2018.
Dr. Liu completed undergraduate studies at The Johns Hopkins University in 2011 and earned a doctorate from Stanford University School of Medicine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
CG ONCOLOGY, INC. 2,23% | 25/06/2026 | 1.886.236 ( 2,23% ) | 134 M $ | 30/06/2026 |
Posizioni attive di Brian Liu
| Società | Posizione | Inizio |
|---|---|---|
| CG ONCOLOGY, INC. | Direttore/Membro del Consiglio | 01/09/2022 |
Longitude Capital Management Co LLC
 Longitude Capital Management Co LLC Investment ManagersFinance Longitude Capital invests in both private and public companies located in the United States. The firm targets companies operating in the fields of medical technology, biotechnology and health solutions. It participates in early stage capital requirements. | Investitore di Private Equity | 01/07/2018 |
Lassen Therapeutics LLC
 Lassen Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage company that develops and manufactures therapeutic antibody products | Direttore/Membro del Consiglio | 01/12/2023 |
Alentis Therapeutics AG
 Alentis Therapeutics AG BiotechnologyHealth Technology Operates as a clinical-stage biotech company that develops therapies to treat cancer and reverse fibrosis | Direttore/Membro del Consiglio | 01/11/2024 |
Precedenti posizioni note di Brian Liu
| Società | Posizione | Fine |
|---|---|---|
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Corporate Officer/Principal | 01/07/2018 |
Formazione di Brian Liu
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
74
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Longitude Capital Management Co LLC
Longitude Capital Management Co LLC Investment ManagersFinance Longitude Capital invests in both private and public companies located in the United States. The firm targets companies operating in the fields of medical technology, biotechnology and health solutions. It participates in early stage capital requirements. | Finance |
CG Oncology, Inc.
 CG Oncology, Inc. BiotechnologyHealth Technology Operates as a late-stage clinical biopharmaceutical company focused on developing and commercializing backbone bladder-sparing therapeutic | Health Technology |
Stanford University School of Medicine
 Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alentis Therapeutics AG
Alentis Therapeutics AG BiotechnologyHealth Technology Operates as a clinical-stage biotech company that develops therapies to treat cancer and reverse fibrosis | Health Technology |
Lassen Therapeutics LLC
Lassen Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage company that develops and manufactures therapeutic antibody products | Commercial Services |
